Apoptosis of vascular smooth muscle cells induced by photodynamic therapy with protoporphyrin IX

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 69-72

  Li, Qingsong ^a   Cheng, Jiali ^a   Peng, Chenghai ^a   Li, Zhitao ^a   Shi, Sa ^a   Liang, Huijuan ^b   Tian, Ye ^a   Zhang, Zhiguo ^b   Cao, Wenwu ^b,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; PDT; Protoporphyrin IX; SMCs

Indexed keywords

PROTOPORPHYRIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL LEVEL; CELL MEMBRANE DEPOLARIZATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; LIGHT INTENSITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TARGET CELL DESTRUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CELL LINE; CORONARY RESTENOSIS; HYPERPLASIA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; TUNICA INTIMA;

EID: 72949103475     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.003     Document Type: Article

References (29)

1. Hermans W.R.M., Rensing B.J., Strauss B.H., and Serruys P.W. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet". Am. Heart J. 122 (1991) 171-187
2. Rogers C., Tseng D.Y., Squire J.C., and Edelman E.R. Balloon-artery interactions during stent placement: a finite element analysis approach to pressure, compliance, and stent design as contributors to vascular injury. Circ. Res. 84 (1999) 378-383
3. Tung R., Kaul S., Diamone G.A., and Shah P.K. Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. Ann. Intern. Med. 144 (2006) 913-919
4. Sharman W.M., Allen C.M., and van Lier J.E. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today 4 (1999) 507-517
5. Rockson S.G., Lorenz D.P., Cheong W.F., and Woodburn K.W. Photoangioplasty: an emerging clinical cardiovascular role for photodynamic therapy. Circulation 102 (2000) 591-596
6. LaMuraglia G.M., Schiereck J., Heckenkamp J., Nigri G., Waterman P., Leszczynski D., and Kossodo S. Photodynamic therapy induces apoptosis in intimal hyperplastic arteries. Am. J. Pathol. 157 (2000) 867-875
7. Heckenkamp J., Aleksic M., Gawenda M., Breuer S., Brabender J., Mahdavi A., Aydin F., and Brunkwall J.S. Modulation of human adventitial fibroblasts function by photodynamic therapy of collagen matrix. Eur. J. Vasc. Endovasc. Surg. 28 (2004) 651-659
8. Adili F., Scholz T., Hille M., Heckenkamp J., Barth S., Engert A., and Schmitz-Rixen T. Photodynamic therapy mediated induction of accelerated re-endothelization following injury to the arterial wall: implication for the prevention of post-interventional restenosis. Eur. J. Vasc. Endovasc. Surg. 24 (2002) 166-175
9. Usui M., Miyagi M., Fukasawa S., Hara T., Ueyama N., Nakajima H., Tarata R., Salame A., Tamura K., Naitou Y., and Yamashina A. A first trial in the clinical application of photodynamic therapy for the prevention of restenosis after coronary-stent placement. Lasers Surg. Med. 34 (2004) 235-241
10. Fisher A.M.R., Murphree A.L., and Gomer C.J. Clinical and preclinical photodynamic therapy. Lasers Surg. Med. 17 (1995) 2-31
11. In: Jori G., Horspool W., and Lenci F. (Eds). CRC Handbook of Organic Photochemistry and Photobiology (2003), CRC Press, Boca Raton 1461-1471
12. Oh-Choon K., Hyeok-Joon Y., Ki-Hong K., Hong-Tae K., Yeon-Hee Y., and Jong-Ki K. Fluorescence kinetics of protoporphyrin-IX induced from 5-ALA compounds in rabbit postballoon injury model for ALA-photoangioplasty. Photochem. Photobiol. 84 (2008) 1209-1214
13. Shy J., O'Brien J.E., Fard A., Mannion J.D., Wang D., and Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94 (1996) 1655-1664
14. Huang Z. A review of progress in clinical photodynamic therapy. Technol. Cancer Res. Treat. 4 (2005) 283-293
15. Star W.M. Light dosimetry in vivo. Phys. Med. Biol. 42 (1997) 763-787
16. Agarwal M.L., Clay M.E., Harvey E.J., Evans H.H., Antunez A.R., and Oleinick N.L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51 (1991) 5993-5996
17. Noodt B.B., Berg K., Stokke T., Peng Q., and Nesland J.M. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br. J. Cancer. 74 (1996) 22-29
18. Kessel D., and Luo Y. Cells in cryptophycin-induced cell-cycle arrest are susceptible to apoptosis. Cancer Lett. 151 (2000) 25-29
19. Hunt D.W., Jiang H., Granville D.J., Chan A.H., Leong S., and Levy J.G. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology 41 (1999) 31-44
20. Jiang H., Granville D.J., McManus B.M., Levy J.G., and Hunt D.W. Selective depletion of a thymocyte subset in vitro with an immuno modulatory photosensitizer. Clin. Immunol. 91 (1999) 178-187
21. Dahle J., Kaalhus O., Moan J., and Steen H. Cooperative effects of photodynamic treatment of cells in microcolonies. Proc. Natl. Acad. Sci. 94 (1997) 1773-1778
22. Dahle J., Steen H.B., and Moan J. The mode of cell death induced by photodynamic treatment depends on cell density. Photochem. Photobiol. 70 (1999) 363-367
23. Dahle J., Bagdonas S., Kaalhus O., Olsen G., Steen H.B., and Moan J. The bystander effect in photodynamic inactivation of cells. Biochim. Biophys. Acta 1475 (2000) 273-280
24. Dahle J., Mikalsen S.O., Rivedal E., and Steen H.B. Gap junctional intercellular communication is not a major mediator in the bystander effect in photodynamic treatment of MDCK II cells. Radiat. Res. 154 (2000) 331-341
25. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Mignotte B., and Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182 (1995) 367-377
26. Pollman M.J., Hall J.L., and Gibbons G.H. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury: influence of redox state and cell phenotype. Circ. Res. 84 (1999) 113-121
27. Heckenkamp J., Aleksic M., Gawenda M., Breuer S.., Brabender J., Mahdavi A., Aydin F., and Brunkwall J.S. Modulation of human adventitial fibroblast function by photodynamic therapy of collagen matrix. Eur. J. Vasc. Endovasc. Surg. 28 (2004) 651-659
28. Overhaus M., Heckenkamp J., Kossodo S., Leszczynski D., and La Muraglia G. Photodynamic therapy generates a matrix barrier to invasive vascular cell migration. Circ. Res. 86 (2000) 334-340
29. Waterman P.R., Overhaus M., Heckenkamp J., Nigri G.R., Fungaloi P.F.C., Landis M.E., Kossodo S.C., and LaMuraglia G.M. Mechanisms of reduced human vascular cell migration after photodynamic therapy. Photochem. Photobiol. 75 (2002) 46-50